Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828243 · ClinicalTrials.gov registry record
Genetic Regulation of Surfactant Deficiency
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 525
- Enrollment target
NCT00828243 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 525 participants.
The verdict
NCT00828243 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 525 participants
- Enrollment target
Study Summary
Inherited deficiencies in any one of 3 genes (surfactant protein B, surfactant protein C, and ATP-binding cassette transporter A3) can cause neonatal respiratory distress syndrome by disrupting metabolism of the pulmonary surfactant. The investigators will use state of the art methods to link specific changes in the genetic code of each of these genes with disruption of discrete steps in the metabolism of the pulmonary surfactant in human newborn infants. These studies will lead to improved diagnostic capabilities and suggest novel strategies to correct surfactant deficiency in newborn infants.
Interventions
- DRUG Nutrient
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 525 participants |
| Start Date | 2007-11 |
| Est. Completion | 2013-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00828243
The ClinicalTrials.gov registry entry for NCT00828243 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 525 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nutrient is the first listed.
NCT00828243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00828243 about?
NCT00828243 is a clinical study titled "Genetic Regulation of Surfactant Deficiency". Inherited deficiencies in any one of 3 genes (surfactant protein B, surfactant protein C, and ATP-binding cassette transporter A3) can cause neonatal respiratory distress syndrome by disrupting metabolism of the pulmonary surfactant. The investigators will use state of the art methods to link specif...
What is the current status of trial NCT00828243?
This trial is currently completed. The enrollment target is 525 participants. The study started on 2007-11. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00828243?
The interventions under investigation include: Nutrient (DRUG).
Who is sponsoring clinical trial NCT00828243?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.